Inhibiting Caspase-6 Activation and Catalytic Activity for Neurodegenerative Diseases

E-ISSN： 1873-4294|14|3|319-325

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.3, 2014-02, pp. : 319-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of Potent Caspase-3 Inhibitors for Treatment of Multi- Neurodegenerative Diseases Using Pharmacophore Modeling and Docking Approaches

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-10 ,pp. : 1346-1353

Bentham Science Publishers

Access to resources Recommend Favorite

Dihydroartemisinin exhibits anti-glioma stem cell activity through inhibiting p-AKT and activating caspase-3

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 10, 2014-10 ,pp. : 752-758

Govi-Verlag

Access to resources Recommend Favorite

Pharmacological Modulation of Caspase Activation

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 4, 2005-08 ,pp. : 407-419

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic receptors and neurodegenerative diseases

By Gualtieri F.

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 85-89

Elsevier

Access to resources Recommend Favorite

Chelating Agents for Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2760-2772

Bentham Science Publishers

Access to resources Recommend Favorite